Marton König

  • Consultant & postdoctoral fellow; MD, PhD
  • +47 23002770
Marton König has completed his medical studies at Semmelweis University Budapest and at the University of Oslo. He conducted research focusing on the role of cannabinoid receptors of the human hippocampus in temporal lobe epilepsy and the development of Purkinje-cells of the cerebellum. He also worked as an intern at the Department of Neurosurgery, Oslo University Hospital (OUH)  in the last two years of his studies. After finishing his medical degree in 2010, he completed an internship in Northern-Norway, followed by 4,5 years at the Department of Neurology at Ostfold Hospital Trust. He worked as a resident, researcher and lecturer at the Department of Neurosurgery, OUH between 2016 and 2021. He completed his PhD degree in 2020 at the University of Oslo, after investigating the multidisciplinary treatment of high-grade malignancies of the skull base. He worked as an associate editor in the Journal of the Norwegian Medical Association between 2018-2020 and is currently associated to the journal as a neuroscientific counsellor.
 
Marton König works as a consultant and postdoctoral fellow at the Department of Neurology, Oslo University Hospital, and as a lecturer at the Departments of Neurology and Behavioural Medicine at the University of Oslo. He is a key researcher in NevroVAX, a study investigating the development of post-vaccination immunity in people with MS, and is involved in research projects focusing on the treatment of patients with multiple sclerosis (NOR-MS, OVERLORD-MS, GAP-MS). 
 

Publications 2023

Frič R, König M, Due-Tønnessen BJ, Ramm-Pettersen J, Berg-Johnsen J (2023)
Long-term outcome of patients treated for craniopharyngioma: a single center experience
Br J Neurosurg, 1-9 (in press)
DOI 10.1080/02688697.2023.2179600, PubMed 36799140

Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K et al. (2023)
Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
NPJ Vaccines, 8 (1), 4
DOI 10.1038/s41541-023-00600-6, PubMed 36697432

Wolf AS, Ravussin A, König M, Øverås MH, Solum G, Kjønstad IF, Chopra A, Holmøy T, Harbo HF, Syversen SW, Jørgensen KK, Høgestøl EA, Vaage JT, Celius EG, Lund-Johansen F, Munthe LA, Nygaard GO, Mjaaland S (2023)
T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis
JCI Insight, 8 (12)
DOI 10.1172/jci.insight.165111, PubMed 37159281

Publications 2022

Hermansen MV, Kleggetveit IP, Ulvin LB, Chawla MS, König M (2022)
A man in his twenties with weakness and numbness in his legs
Tidsskr Nor Laegeforen, 142 (1)
DOI 10.4045/tidsskr.22.0642, PubMed 36655972

König M, Torgauten HM, Tran TT, Holmøy T, Vaage JT, Lund-Johansen F, Nygaard GO (2022)
Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination
JAMA Neurol, 79 (3), 307-309
DOI 10.1001/jamaneurol.2021.5109, PubMed 35072702

Riise J, Meyer S, Blaas I, Chopra A, Tran TT, Delic-Sarac M, Hestdalen ML, Brodin E, Rustad EH, Dai KZ, Vaage JT, Nissen-Meyer LSH, Sund F, Wader KF, Bjornevik AT, Meyer PA, Nygaard GO, König M, Smeland S, Lund-Johansen F, Olweus J, Kolstad A (2022)
Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination
Br J Haematol, 197 (6), 697-708
DOI 10.1111/bjh.18149, PubMed 35254660

Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K et al. (2022)
Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
NPJ Vaccines, 7 (1), 174
DOI 10.1038/s41541-022-00586-7, PubMed 36585405

Publications 2021

Corniola MV, König M, Meling TR (2021)
STA-MCA Bypass in Carotid Stenosis after Radiosurgery for Cavernous Sinus Meningioma
Cancers (Basel), 13 (10)
DOI 10.3390/cancers13102420, PubMed 34067741

Konig M, Koht JA (2021)
Unilateral erythema or unilateral pallor?
Tidsskr. Nor. Laegeforen., 141 (12), 1205

König M, Koht JA (2021)
Unilateral erythema or unilateral pallor?
Tidsskr Nor Laegeforen, 141
DOI 10.4045/tidsskr.21.0319, PubMed 34505470

König M, Lorentzen ÅR, Torgauten HM, Tran TT, Schikora-Rustad S, Vaage EB, Mygland Å, Wergeland S, Aarseth J, Aaberge IAS, Torkildsen Ø, Holmøy T, Berge T, Myhr KM, Harbo HF, Andersen JT, Munthe LA, Søraas A, Celius EG, Vaage JT, Lund-Johansen F, Nygaard GO (2021)
Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations
J Neurol Neurosurg Psychiatry, 94 (1), 19-22
DOI 10.1136/jnnp-2021-327612, PubMed 34670844

Publications 2020

Konig M (2020)
Hidden treasures
Tidsskr. Nor. Laegeforen., 140 (11), 1085

König M (2020)
Hidden treasures
Tidsskr Nor Laegeforen, 140 (11)
DOI 10.4045/tidsskr.20.0622, PubMed 32815330

König M, Osnes T, Bruland Ø, Sundby Hall K, Bratland Å, Meling TR (2020)
The Role of Adjuvant Treatment in Craniofacial Malignancy: A Critical Review
Front Oncol, 10, 1402
DOI 10.3389/fonc.2020.01402, PubMed 32850452

Publications 2019

Konig M (2019)
What would Winnie the Pooh have said?
Tidsskr. Nor. Laegeforen., 139 (16), 1527

König M (2019)
What would Winnie the Pooh have said?
Tidsskr Nor Laegeforen, 139 (16)
DOI 10.4045/tidsskr.19.0679, PubMed 31686472

König M, Osnes T, Bratland Å, Jebsen P, Meling TR (2019)
Treatment of Sinonasal Adenocarcinoma: A Population-Based Prospective Cohort Study
J Neurol Surg B Skull Base, 81 (6), 627-637
DOI 10.1055/s-0039-1694050, PubMed 33381366

König M, Osnes T, Bratland Å, Meling TR (2019)
Squamous Cell Carcinoma of the Paranasal Sinuses: A Single Center Experience
J Neurol Surg B Skull Base, 81 (6), 664-672
DOI 10.1055/s-0039-1694967, PubMed 33381371

Publications 2018

König M, Osnes T, Jebsen P, Meling TR (2018)
Craniofacial resection of malignant tumors of the anterior skull base: a case series and a systematic review
Acta Neurochir (Wien), 160 (12), 2339-2348
DOI 10.1007/s00701-018-3716-4, PubMed 30402666

Publications 2017

Konig M (2017)
Acute neurologists Reply
Tidsskr. Nor. Laegeforen., 137 (4), 260-261

König M (2017)
[Not Available]
Tidsskr Nor Laegeforen, 137 (4), 260-261
DOI 10.4045/tidsskr.17.0103, PubMed 28225227

König M, Osnes T, Jebsen P, Evensen JF, Meling TR (2017)
Olfactory neuroblastoma: a single-center experience
Neurosurg Rev, 41 (1), 323-331
DOI 10.1007/s10143-017-0859-3, PubMed 28540633

Publications 2016

König M, Osnes TA, Lobmaier I, Bjerkehagen B, Bruland ØS, Sundby Hall K, Meling TR (2016)
Multimodal treatment of craniofacial osteosarcoma with high-grade histology. A single-center experience over 35 years
Neurosurg Rev, 40 (3), 449-460
DOI 10.1007/s10143-016-0802-z, PubMed 27858303

Publications 2014

König MS, Osnes T, Meling TR (2014)
Treatment of esthesioneuroblastomas
Neurochirurgie, 60 (4), 151-7
DOI 10.1016/j.neuchi.2014.03.007, PubMed 24975203

Publications 2011

König M, Bakke SJ, Scheie D, Sorteberg W, Meling TR (2011)
Reactive expansive intracerebral process as a complication of endovascular coil treatment of an unruptured intracranial aneurysm: case report
Neurosurgery, 68 (5), E1468-73; discussion E1473-4
DOI 10.1227/NEU.0b013e318210c7c0, PubMed 21307790

Publications 2010

König M, Due-Tønnessen B, Osnes T, Haugstvedt JR, Meling TR (2010)
Median facial cleft with a frontoethmoidal encephalocele treated with craniofacial bipartition and free radial forearm flap: a case report
Skull Base, 20 (2), 119-23
DOI 10.1055/s-0029-1238216, PubMed 20808538

König M, Mork J, Hall KS, Osnes T, Meling TR (2010)
Multimodal treatment of osteogenic sarcoma of the jaw
Skull Base, 20 (3), 207-12
DOI 10.1055/s-0029-1246221, PubMed 21318040

Page visits: 2784
Scroll to top